Green Bay Packers’ Clay Matthews Supports CureDuchenne ‘My Cause My Cleats’
Matches Donations to Fund Duchenne Research
NEWPORT BEACH, CA (December 2, 2017) – In Week 13 of the NFL season, Clay Matthews of the Green Bay Packers will take to the field with his heart on his feet. This year, the NFL is continuing its ‘My Cause My Cleats’ campaign where NFL players design cleats to raise awareness for an organization near and dear to their hearts. A longtime supporter of those who battle Duchenne muscular dystrophy, Clay Matthews’ cleats will support CureDuchenne, a national nonprofit that raises awareness and funds research to find a cure for Duchenne. Join Matthews in helping fund the cure for Duchenne. Starting today, Matthews will match donations up to $25,000 until Monday, December 4 at midnight. One hundred percent of the donations will go to funding Duchenne research.
In an NFL video about his cleats and why CureDuchenne matters to him, Matthews explains that boys who battle this degenerative disease are his heroes, and he will proudly wear cleats designed by two boys with Duchenne. As part of the effort, Matthews encouraged boys to submit designs and he chose one for each foot. Two final designs were selected and combined to create the final cleats Mathews will wear in the Sunday, Dec. 3 game against the Tampa Bay Buccaneers.
Matthews has supported CureDuchenne since 2010 when he recorded a public service announcement for the organization. He regularly corresponds with boys with Duchenne, and aims to give them hope for their future. Presently there is no cure and there are limited treatments to stem the muscle degeneration caused by Duchenne.
Found mostly in boys, Duchenne muscular dystrophy causes muscle degeneration, growing worse as patients get older. Those with Duchenne often lose their ability to walk by their mid-teens and the disease claims their lives by their mid-20s. Duchenne affects one in 5,000 boys in the U.S.
Join Matthews and help fund research to find a cure for Duchenne.
CureDuchenne was founded in 2003 with a focus on saving the lives of those with Duchenne muscular dystrophy, a disease that affects more than 300,000 children and young adults worldwide. With support from CureDuchenne, nine research projects have advanced to human clinical trials. CureDuchenne also brings physical therapy and standard of care to local communities around the country through its CureDuchenne Cares program. For more information, please visit CureDuchenne.org and follow us on Facebook, Twitter, Instagram and YouTube.